Innate Pharma (IPHA) Shares Outstanding (2017 - 2025)

Innate Pharma (IPHA) has reported Shares Outstanding (Entity) for 9 consecutive years, with $102.42 the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 11.11% year-over-year to $102.42 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $102.42 (up 11.11% YoY) and the FY2025 annual result came in at $102.42, up 11.11% from the prior year.
• Shares Outstanding (Entity) rose to $102.42 in Q4 2025 per IPHA's latest filing, from $99.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for IPHA reached as high as $102.42 in Q4 2025 and fell as low as $89.9 in Q2 2021.
• A 5-year average of $93.08 and a median of $91.04 in 2021 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) changed 0.0% — and 2025, when it increased 11.11%.
• Year by year, Shares Outstanding (Entity) stood at $91.04 in 2021, then changed by 0.0% to $91.04 in 2022, then changed by 0.0% to $91.04 in 2023, then climbed by 1.25% to $92.17 in 2024, then advanced by 11.11% to $102.42 in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $102.42, $99.0, and $92.17 for Q4 2025, Q2 2025, and Q4 2024 respectively.